FDA rejects Bill Godshall’s request to present scientific and empirical evidence on vaping (at FDA’s so-called public workshop on June 1 & 2) on the following topics:
- pertinent findings and analysis of different surveys on prevalence and patterns of e-cigarette use among adult and teen smokers, former smokers and never (or non) smokers. - pertinent findings and analysis of different surveys of vapers (aka e-cigarette users) on vapor product usage patterns for different types of vapor products (e.g. “cigalike” e-cigarettes, premium vaporizers, e-liquids, flavorings and nicotine-free products), as well as cigarette usage patterns among vapers.
- available e-cigarette industry sales data and sales estimates for different types of vapor products, and for different marketing channels (e.g. convenience stores, vape shops, tobacco specialty stores, Internet).
